Recurrence of Dupuytren*s Disease after treatment with Collagenase Clostridium Histolyticum in the thumb.

Completed

• Conditions: Dupuytren's Disease; fibromatosis palmaris; 10043237

• Registration Number: NL-OMON42619
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 12

Inclusion Criteria

12 subjects who had CCH treatment in 14 thumbs during previous study.

Exclusion Criteria

Subjects who had new treatment of the thumb or first webspace since their treatment with CCH will be excluded

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Contractures are measured with a goniometer. Baseline is the measurement of<br /><br>ROM in degrees of the extension deficit as measured 30 days after the<br /><br>injection with CCH . We measure the mean increase of contracture and the<br /><br>deviation.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>